Full-Time

Clinical Laboratory Associate

Cla

Confirmed live in the last 24 hours

BillionToOne

BillionToOne

201-500 employees

Molecular diagnostics for prenatal and oncology testing

Biotechnology
Healthcare

Compensation Overview

$26Hourly

Entry

Hayward, CA, USA

Onsite position in Union City.

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • Bachelor’s degree or equivalent in biology or clinical related sciences
  • At least 6 months of experience with molecular biology techniques in a research or clinical laboratory
  • Excellent attention to detail
  • Effective written and verbal communication skills
  • The ability to multitask and work independently
  • Previous clinical laboratory experience is preferred
Responsibilities
  • Perform sample accessioning and isolation procedures according to the laboratory’s standard operating procedures;
  • Prepare documents for equipment and personnel records;
  • Perform and document routine maintenance of equipment;
  • Prepare other clinical documentation as required and assigned;
  • Clean labware, equipment, and benches;
  • Prepare reagents required for testing;
  • Write and review controlled documents as assigned

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair level, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne's business model centers on providing these diagnostic services directly to healthcare providers, generating revenue through the sale of testing services that inform treatment decisions. The goal of BillionToOne is to enhance the accuracy, efficiency, and accessibility of molecular testing, driven by a commitment to growth, equality, and teamwork in making a positive impact on healthcare.

Company Stage

Series D

Total Funding

$380.2M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

10%

1 year growth

22%

2 year growth

77%
Simplify Jobs

Simplify's Take

What believers are saying

  • BillionToOne's expansion in Austin will create 1,000 jobs, boosting local biotech growth.
  • Rising demand for non-invasive prenatal testing supports BillionToOne's market expansion.
  • Recent $130M funding round boosts BillionToOne's valuation to over $1 billion.

What critics are saying

  • Emerging startups in molecular diagnostics could threaten BillionToOne's market share.
  • Rapid technological advancements may render BillionToOne's technology obsolete.
  • Ethical concerns about genetic testing could lead to stricter regulations.

What makes BillionToOne unique

  • BillionToOne's QCT technology detects DNA variations at single base-pair resolution.
  • Their non-invasive prenatal tests replace risky procedures like amniocentesis.
  • BillionToOne's UNITY Fetal Antigen NIPT is the first to include antigens beyond RhD.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging